US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hemab Therapeutics Holdings, Inc.

40.45

+1.052.66%

Volume:327.03K

Turnover:13.00M

Market Cap:1.89B

PE:-22.70

High:40.88

Open:39.40

Low:38.79

Close:39.40

52wk High:55.42

52wk Low:23.00

Shares:46.71M

Float Shares:16.75M

Volume Ratio:0.94

T/O Rate:1.95%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7820

EPS(LYR):-67.5613

ROE:-46.99%

ROA:-30.11%

PB:4.16

PE(LYR):-0.60

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Hemab Therapeutics Holdings, Inc. (COAG) Gets a Buy from Wedbush

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Hemab Therapeutics' Q2 Net Loss Narrows

MT Newswires Live

Earnings Flash (COAG) Hemab Therapeutics Posts Q2 Net Loss $0.80 a Share, vs. FactSet Est of $0.56 Loss

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/COAG"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"COAG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","market":"US","secType":"STK","nameCN":"Hemab Therapeutics Holdings, Inc.","latestPrice":40.45,"timestamp":1789413581969,"preClose":39.4,"halted":0,"volume":327029,"delay":0,"changeRate":0.02664974619289351,"floatShares":16750000,"shares":46705400,"eps":-1.782,"marketStatus":"Trading","change":1.05,"latestTime":"09-14 15:19:46 EDT","open":39.4,"high":40.88,"low":38.79,"amount":12999100.902233,"amplitude":0.053046,"askPrice":40.52,"askSize":103,"bidPrice":40.39,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-1.782,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":39.4,"postHourTrading":{"tag":"盘后","latestPrice":39.4,"preClose":39.4,"latestTime":"19:04 EDT","volume":30,"amount":1182.69,"timestamp":1789167844018,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.942558},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","floatShares":16750000,"roa":"-30.11%","roe":"-46.99%","lyrEps":-67.56131,"volumeRatio":0.942558,"shares":46705400,"dividePrice":0,"high":40.88,"amplitude":0.053046,"preClose":39.4,"low":38.79,"week52Low":23.0001,"pbRate":"4.16","week52High":55.42,"institutionHeld":0,"latestPrice":40.45,"committee":-0.961905,"eps":-1.782,"divideRate":0,"volume":327029,"delay":0,"ttmEps":-1.782,"open":39.4,"prevYearClose":18,"prevWeekClose":39.4,"prevMonthClose":45.73,"prevQuarterClose":36.73,"fiveDayClose":44.41,"twentyDayClose":54.94,"sixtyDayClose":26.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COAG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"COAG","fiscalQuarterEnding":"2026/06","expectedEps":-0.63,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COAG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COAG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COAG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COAG","date":"2026-09-11","current":-22.699214,"percent":0.511111,"low":-34.170536,"twenty":-29.479949,"median":-23.509442,"eighty":-18.159648,"high":-11.042152,"avg":-23.686128,"sd":5.485186,"marketCap":1862879225},"quantilePoints":[{"date":"2026-05-01","current":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"marketCap":705737088},{"date":"2026-05-08","current":-17.79803,"twenty":-17.79803,"median":-17.407359,"eighty":-17.286354,"marketCap":1137525503},{"date":"2026-05-15","current":-19.616555,"twenty":-19.616555,"median":-17.521449,"eighty":-17.286354,"marketCap":1253752856},{"date":"2026-05-22","current":-18.185245,"twenty":-19.409118,"median":-17.853347,"eighty":-17.293269,"marketCap":1162273533},{"date":"2026-05-29","current":-19.360717,"twenty":-19.450605,"median":-18.046954,"eighty":-17.354117,"marketCap":1237401480},{"date":"2026-06-05","current":-17.56985,"twenty":-19.450605,"median":-18.185245,"eighty":-17.491025,"marketCap":1122941843},{"date":"2026-06-12","current":-18.627775,"twenty":-19.370397,"median":-18.1403,"eighty":-17.515917,"marketCap":1190556995},{"date":"2026-06-18","current":-18.288963,"twenty":-19.294337,"median":-18.002009,"eighty":-17.444006,"marketCap":1168902469},{"date":"2026-06-26","current":-18.159648,"twenty":-19.492093,"median":-18.185245,"eighty":-17.510385,"marketCap":1294673965},{"date":"2026-07-02","current":-21.291074,"twenty":-19.764526,"median":-18.302792,"eighty":-17.540809,"marketCap":1517925825},{"date":"2026-07-10","current":-24.370091,"twenty":-20.501011,"median":-18.714206,"eighty":-17.578148,"marketCap":1737441252},{"date":"2026-07-17","current":-29.172047,"twenty":-21.688778,"median":-18.837687,"eighty":-17.609955,"marketCap":2079791907},{"date":"2026-07-24","current":-30.02369,"twenty":-24.062189,"median":-19.305401,"eighty":-17.650059,"marketCap":2140508940},{"date":"2026-07-31","current":-31.09807,"twenty":-25.689482,"median":-19.512836,"eighty":-17.666654,"marketCap":2217105812},{"date":"2026-08-07","current":-34.170536,"twenty":-29.287346,"median":-19.706444,"eighty":-17.692929,"marketCap":2436154185},{"date":"2026-08-14","current":-30.277152,"twenty":-30.021629,"median":-19.996854,"eighty":-17.818774,"marketCap":2520118712},{"date":"2026-08-21","current":-27.050208,"twenty":-30.064832,"median":-20.629413,"eighty":-17.903131,"marketCap":2251524039},{"date":"2026-08-28","current":-27.774166,"twenty":-30.021629,"median":-21.296443,"eighty":-17.946001,"marketCap":2311782670},{"date":"2026-09-04","current":-24.900782,"twenty":-29.906697,"median":-22.201677,"eighty":-18.108214,"marketCap":2072616631},{"date":"2026-09-11","current":-22.38096,"twenty":-29.479949,"median":-23.509442,"eighty":-18.159648,"marketCap":1862879225}],"updateTime":1789413586179},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COAG\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658903312","title":"Hemab Therapeutics Holdings, Inc. (COAG) Gets a Buy from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903312?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:55","pubTimestamp":1786542934,"startTime":"0","endTime":"0","summary":"Wedbush analyst David Nierengarten maintained a Buy rating on Hemab Therapeutics Holdings, Inc. today and set a price target of $64.00. According t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/hemab-therapeutics-holdings-inc-coag-gets-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/hemab-therapeutics-holdings-inc-coag-gets-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658276289","title":"U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage","url":"https://stock-news.laohu8.com/highlight/detail?id=2658276289","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658276289?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:07","pubTimestamp":1786522040,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public StorageAug 12 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, inclu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4N4490GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANF","EXR","HD","TGT","LOW","REZ","AUAU","MRCY","MAA","ACM","ARKG","RSPS","COAG","LEGN","JBIO","ACVA","RPD","SR","NTRA","LITE","CAH","FLUT","CAVA","LAZR","HLIO","CANC","CUBE","MNST","PNW","NEM","ODDZ","LPTH","PSA","SGMT","EGGY","BCAX","CRWV","AMBQ","CRCL","JAZZ","BLCK","GAP","LBRX","MDLN","CVS","BBIO","TXG","LENZ","FXU","GDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997813","title":"Hemab Therapeutics' Q2 Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997813","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997813?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:33","pubTimestamp":1786447990,"startTime":"0","endTime":"0","summary":"Hemab Therapeutics (COAG) reported a Q2 net loss Tuesday of $0.80 per diluted share, narrowing from a $12.91 loss per share a year earlier.One analyst polled by FactSet expected a $0.56 loss per share.No revenue was reported for the period.Hemab Therapeutics shares were down 1.7% premarket Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4539","BK4139","COAG","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992182","title":"Earnings Flash (COAG) Hemab Therapeutics Posts Q2 Net Loss $0.80 a Share, vs. FactSet Est of $0.56 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992182","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992182?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:16","pubTimestamp":1786446960,"startTime":"0","endTime":"0","summary":"Earnings Flash (COAG) Hemab Therapeutics Posts Q2 Net Loss $0.80 a Share, vs. FactSet Est of $0.56 Loss","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/COAG\",params:#limit:6,delay:false,,,undefined,":[]}}